Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
April 23, 2024 05:18 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
April 17, 2024 03:13 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
Diet Pills Global Market Report 2024: The Rise of Plant-Based and Technological Innovations
January 24, 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Diet Pills Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest market research sheds light on the remarkable...
Zepbound™ New Injectable Weight Loss Medication Coming to St. Louis
November 10, 2023 11:00 ET
|
St. Louis Bariatrics
St Louis, MO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Food and Drug Administration has granted approval for Zepbound™, an innovative weight loss medication developed by Eli Lilly. In clinical trials,...
Key Trends and Opportunities in the Global Weight Loss Products and Services Market to 2026
August 03, 2021 04:23 ET
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Weight Loss Products and Services Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for weight...